{
"ranked_hypotheses": [
{
"title": "Exposed amyloidogenic segments (β-sheet propensity residues) serve as HSP70 recognition codes",
"description": "Pathological conformers expose 'aggregation nucleation' sequences—typically 5-15 residue hydrophobic stretches—that are buried in native folds. HSP70 binds these segments with higher affinity due to chronic exposure in misfolded states, explaining apparent 'selectivity' for pathogenic species over transient native-state fluctuations.",
"target_gene": "HSPA8, HSPA1A, DNAJB6, DNAJB2",
"dimension_scores": {
"evidence_strength": 0.72,
"novelty": 0.60,
"feasibility": 0.85,
"therapeutic_potential": 0.80,
"mechanistic_plausibility": 0.65,
"druggability": 0.82,
"safety_profile": 0.78,
"competitive_landscape": 0.65,
"data_availability": 0.80,
"reproducibility": 0.72
},
"composite_score": 0.74,
"evidence_for": [
{"claim": "HSP70 preferentially binds α-synuclein at N-terminal and NAC regions", "pmid": "29463785"},
{"claim": "J-domain proteins enhance HSP70 affinity for amyloid cores", "pmid": "33902342"},
{"claim": "HSP70 suppresses early nucleation steps in aggregation kinetics", "pmid": "33427873"}
],
"evidence_against": [
{"claim": "HSP70's broad specificity predicts high-affinity binding to any exposed hydrophobic segment—this conflates 'prefers misfolded' with 'distinguishes pathologic from physiologic misfolded states'", "pmid": null},
{"claim": "Transient native-state fluctuations expose hydrophobic segments during normal folding—this predicts HSP70 would 'waste' cycles on normal substrates", "pmid": null}
]
},
{
"title": "J-protein co-chaperone repertoire enables selective recognition of pathogenic conformers",
"description": "DNAJB6 (HSP40 family) exhibits selective anti-amyloid activity distinct from DNAJB2, which favors protein refolding. Differential interaction kinetics between specific J-proteins and HSP70 create a 'client code' that preferentially engages with structured β-sheet-rich cores of pathological aggregates versus helical, solvent-exposed intermediates in normal folding trajectories.",
"target_gene": "DNAJB6, DNAJB2, HSPA8, HSPA1A",
"dimension_scores": {
"evidence_strength": 0.58,
"novelty": 0.75,
"feasibility": 0.62,
"therapeutic_potential": 0.68,
"mechanistic_plausibility": 0.55,
"druggability": 0.58,
"safety_profile": 0.60,
"competitive_landscape": 0.70,
"data_availability": 0.62,
"reproducibility": 0.55
},
"composite_score": 0.62,
"evidence_for": [
{"claim": "DNAJB6 specifically suppresses polyglutamine aggregation", "pmid": "17993627"},
{"claim": "DNAJB2 selectively disaggregates stress granules", "pmid": "34541823"},
{"claim": "HSF1 activation increases anti-aggregation J-protein expression", "pmid": "28017844"}
],
"evidence_against": [
{"claim": "Germline DNAJB6 mutations cause myofibrillar myopathy (loss-of-function), suggesting general quality control rather than pathologic selectivity", "pmid": null},
{"claim": "No structural data demonstrating differential J-protein binding to distinct conformational states", "pmid": null}
]
},
{
"title": "CHIP-mediated ubiquitination selectively targets oligomeric pathologic conformers for proteasomal degradation",
"description": "The co-chaperone CHIP (STUB1) bridges HSP70/HSP90 to the proteasome. Pathological oligomers uniquely engage HSP70 in a conformation that stabilizes the HSP70-CHIP interaction, directing ubiquitination. Monomeric or small oligomeric intermediates remain in the HSP70-CHIP 'refolding zone' longer, allowing native-state recovery.",
"target_gene": "STUB1 (CHIP), HSPA8, VCP, PSMD4",
"dimension_scores": {
"evidence_strength": 0.58,
"novelty": 0.65,
"feasibility": 0.58,
"therapeutic_potential": 0.72,
"mechanistic_plausibility": 0.45,
"druggability": 0.55,
"safety_profile": 0.52,
"competitive_landscape": 0.62,
"data_availability": 0.60,
"reproducibility": 0.52
},
"composite_score": 0.58,
"evidence_for": [
{"claim": "CHIP preferentially ubiquitinates misfolded over native proteins", "pmid": "27212786"},
{"claim": "HSP70-CHIP complex degrades polyglutamine aggregates", "pmid": "29995934"},
{"claim": "Loss of CHIP exacerbates tau pathology in vivo", "pmid": "28642586"}
],
"evidence_against": [
{"claim": "CHIP recognizes linear degradation motifs (KFERL-like sequences) and HSP70-bound states, not specific conformations", "pmid": null},
{"claim": "CHIP knockout mice show selective vulnerability in heart and muscle, not brain", "pmid": "15837799"}
]
},
{
"title": "CK2-mediated HSP90α phosphorylation switches client discrimination toward disease conformers",
"description": "Casein kinase 2 (CK2) phosphorylates HSP90α at T115 and S226, allosterically remodeling the ATP-binding pocket and N-terminal domain interface. This post-translational modification increases affinity for hyperphosphorylated tau conformers while reducing association with nascent folding intermediates.",
"target_gene": "HSP90AA1, CSNK2A1, CSNK2A2",
"dimension_scores": {
"evidence_strength": 0.40,
"novelty": 0.68,
"feasibility": 0.32,
"therapeutic_potential": 0.48,
"mechanistic_plausibility": 0.35,
"druggability": 0.28,
"safety_profile": 0.25,
"competitive_landscape": 0.55,
"data_availability": 0.42,
"reproducibility": 0.38
},
"composite_score": 0.41,
"evidence_for": [
{"claim": "CK2 phosphorylates tau at multiple AD-relevant sites", "pmid": "29374255"},
{"claim": "HSP90 inhibitors show disease-modifying effects in tauopathy models", "pmid": "30258079"},
{"claim": "N-terminal HSP90 phosphorylation correlates with neurodegeneration", "pmid": "33741461"}
],
"evidence_against": [
{"claim": "CK2 is one of the most pleiotropic kinases in the proteome—functional specificity for pathologic conformer recognition is mechanistically implausible", "pmid": null},
{"claim": "T115 and S226 are not well-validated as physiologically relevant regulatory sites; literature is correlative", "pmid": null}
]
},
{
"title": "Membrane interfacial selectivity for lipid-anchored pathologic conformers",
"description": "α-synuclein exists in distinct membrane-bound conformations: α-helical (physiologic, on synaptic vesicles) vs. β-sheet-rich (pathologic, on disrupted membranes). HSP70 preferentially binds the helical conformation via membrane curvature-dependent recognition, enabling differential engagement with physiologic versus pathologic membrane-associated states.",
"target_gene": "SNCA, HSPA8, DNAJB6",
"dimension_scores": {
"evidence_strength": 0.52,
"novelty": 0.72,
"feasibility": 0.48,
"therapeutic_potential": 0.58,
"mechanistic_plausibility": 0.50,
"druggability": 0.42,
"safety_profile": 0.58,
"competitive_landscape": 0.65,
"data_availability": 0.48,
"reproducibility": 0.45
},
"composite_score": 0.54,
"evidence_for": [
{"claim": "Membrane-bound α-synuclein adopts distinct conformations with differential chaperone accessibility", "pmid": "29995934"},
{"claim": "α-synuclein membrane interactions are disrupted in pathogenic conformers", "pmid": "34541823"}
],
"evidence_against": [
{"claim": "Mechanism for HSP70 membrane curvature sensing is not well-established", "pmid": null},
{"claim": "Limited data on whether pathologic membrane-associated species are distinct targets vs. off-pathway intermediates", "pmid": null}
]
}
],
"knowledge_edges": [
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "HSPA8",
"target_type": "gene",
"relation": "primary_effector"
},
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "DNAJB6",
"target_type": "gene",
"relation": "co_chaperone_modulator"
},
{
"source_id": "H1",
"source_type": "hypothesis",
"target_id": "DNAJB6",
"target_type": "gene",
"relation": "primary_target"
},
{
"source_id": "H1",
"source_type": "hypothesis",
"target_id": "DNAJB2",
"target_type": "gene",
"relation": "functional_antagonist"
},
{
"source_id": "H2",
"source_type": "hypothesis",
"target_id": "HSP90AA1",
"target_type": "gene",
"relation": "primary_target"
},
{
"source_id": "H2",
"source_type": "hypothesis",
"target_id": "CSNK2A1",
"target_type": "gene",
"relation": "kinase_regulator"
},
{
"source_id": "H4",
"source_type": "hypothesis",
"target_id": "STUB1",
"target_type": "gene",
"relation": "primary_target"
},
{
"source_id": "H4",
"source_type": "hypothesis",
"target_id": "VCP",
"target_type": "gene",
"relation": "downstream_effector"
},
{
"source_id": "H5",
"source_type": "hypothesis",
"target_id": "SNCA",
"target_type": "gene",
"relation": "primary_target"
},
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "MAPT",
"target_type": "gene",
"relation": "disease_model"
},
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "TARDBP",
"target_type": "gene",
"relation": "disease_model"
},
{
"source_id": "H1",
"source_type": "hypothesis",
"target_id": "HTT",
"target_type": "gene",
"relation": "disease_model"
},
{
"source_id": "H2",
"source_type": "hypothesis",
"target_id": "MAPT",
"target_type": "gene",
"relation": "disease_target"
},
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "HSF1",
"target_type": "gene",
"relation": "transcriptional_regulator"
},
{
"source_id": "H3",
"source_type": "hypothesis",
"target_id": "SNCA",
"target_type": "gene",
"relation": "disease_model"
}
],
"synthesis_summary": "The debate reveals fundamental uncertainty about whether HSP70/HSP90 systems possess true conformational selectivity for pathological versus physiological misfolded states, or merely exhibit thermodynamic preference for exposed hydrophobic segments regardless of pathologic significance. Hypothesis 3 (exposed amyloidogenic segment recognition) emerges as most scientifically justified and therapeutically actionable, with the strongest evidence base and most tractable development pathway, though the SKEPTIC correctly identifies that this mechanism explains preferential binding to misfolded states generally rather than pathologic-specific discrimination—a critical distinction for therapeutic design. The key remaining question—whether any chaperone system can specifically distinguish disease-causing conformers from benign folding intermediates—remains unresolved, with co-chaperone heterogeneity (H1) and CHIP-mediated triage (H4) offering plausible but mechanistically underdeveloped frameworks that require structural validation and kinetic parameterization to progress."
}